Skip to main content

. 1958 Nov 1;2(5104):1070–1072. doi: 10.1136/bmj.2.5104.1070

Toxic Effects of Iproniazid in a Patient with Angina

Cornelio Papp, S Benaim

PMCID: PMC2026825 PMID: 13584852

1070

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

CESARMAN T. Marsilid in the treatment of angina pectoris. J Clin Exp Psychopathol. 1958 Apr-Jun;19(2 Suppl 1):169–177. [PubMed] [Google Scholar]
COSSIO P. Tratamiento de la angina de pecho y de otros dolores isquémicos por el fosfato de iproniazida. Rev Med Chil. 1958 Feb;86(2):67–86. [PubMed] [Google Scholar]
DALLY P. J. Indications for use of iproniazid in psychiatric practice. Br Med J. 1958 Jun 7;1(5083):1338–1339. doi: 10.1136/bmj.1.5083.1338. [DOI] [PMC free article] [PubMed] [Google Scholar]
DUNDEE J. W., TINCKLER L. F. Pethidine and liver damage. Br Med J. 1952 Sep 27;2(4786):703–704. doi: 10.1136/bmj.2.4786.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
FOUTS J. R., BRODIE B. B. On the mechanism of drug potentiation by iproniazid (2-isopropyl-1-isonicotinyl hydrazine). J Pharmacol Exp Ther. 1956 Apr;116(4):480–485. [PubMed] [Google Scholar]
MITCHELL R. S. Fatal toxic encephalitis occurring during iproniazid therapy in pulmonary tuberculosis. Ann Intern Med. 1955 Feb;42(2):417–424. doi: 10.7326/0003-4819-42-2-417. [DOI] [PubMed] [Google Scholar]
O'CONNOR J. B., HOWLETT K. S., Jr, WAGNER R. R. Side effects accompanying use of iproniazid. Am Rev Tuberc. 1953 Aug;68(2):270–272. doi: 10.1164/art.1953.68.2.270. [DOI] [PubMed] [Google Scholar]
SCHERBEL A. L. The effect of marsilid in patients having rheumatoid arthritis; the theoretical causal role of certain amine oxidases. J Clin Exp Psychopathol. 1958 Apr-Jun;19(2 Suppl 1):118–122. [PubMed] [Google Scholar]

ACTIONS

RESOURCES